Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

AZO GANTANOL

PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE

Standard Dose
100MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview AZO GANTANOL is listed in Drugs@FDA under application 013294 (NDA).

Marketing status: Discontinued Active ingredient PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE Form and strength TABLET;ORAL - 100MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROCHE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview AZO GANTANOL is listed in Drugs@FDA under application 013294 (NDA). Marketing status: Discontinued Active ingredient PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE Form and strength TABLET;ORAL - 100MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ROCHE Submission history See approval history documents.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.